Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FILLOX MAJORSTUEN AS
AS
Active
Org 931950274
Valkyriegata 19, 0366 Oslo
General medical practice activities · NACE 8621
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 5,5M
+45% vs 2023
EBITDA margin
0.1%
-99% vs 2023
Equity ratio
17.3%
Financial strength
Net profit 2024
NOK -38K
-107% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
NOK 5,5M
+45%
EBITDA
NOK 6K
-99%
Net profit
NOK -38K
-107%
Total assets
NOK 2,9M
+12%
Equity
NOK 509K
-7%
Employees
1
—
Company information
Legal name
FILLOX MAJORSTUEN AS
Org number
931950274
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
16. oktober 2023
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Medisinske og estetiske behandlinger og andre helsetjenester.
Contact
Address
Valkyriegata 19, 0366 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
4M
2023
5M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
3 778
5 485
Staff expenses
−1 244
−1 847
EBITDA
683
6
Depreciation & amort.
−14
−48
EBIT
669
−42
Net financials
0
−2
Profit before tax
669
−44
Tax
147
−6
Net profit
522
−38
Balance sheet
NOK thousands
Item
2023
2024
Total assets
2 638
2 947
Equity
546
509
Long-term debt
6
0
Short-term debt
2 085
2 439
Total debt
2 091
2 439
Financial ratios
5-year trend
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
2023
2024
Equity ratio
17.3%
This company
38.2%
Market median
-55% vs market
2023
2024
Return on equity
-7.4%
This company
18.4%
Market median
-140% vs market
2023
2024
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
2023
2024
Asset turnover
1.86×
This company
1.12×
Market median
+66% vs market
2023
2024
Debt / equity
4.80×
This company
0.62×
Market median
-674% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TH
Tom Haugland
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AL
Anette Lynne
Chairman
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Fillox As
Company
70%
70%
2024
Blancodor Holding As
Company
20%
20%
2024
Justyna Holding As
Company
10%
10%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Justyna Holding As
FILLOX MAJORSTUEN AS
(this company)
Board network connections
Board members of FILLOX MAJORSTUEN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Tom Haugland
Chief Executive Officer
0 companies
Anette Lynne
Chairman
0 companies